| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 52.5769 | 55 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.9149 | 41 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.5512 | 50 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.4219 | 50 |
| GSM780720 | Untreated after 4 days (C2_2) | 63.69 | 67 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.7736 | 21 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.4939 | 30 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 58.9764 | 64 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.3438 | 61 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.2312 | 42 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 63.424 | 66 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.6722 | 53 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 59.2609 | 64 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.0195 | 54 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 57.4155 | 62 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.5393 | 47 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.5628 | 50 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 54.7956 | 59 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 58.1933 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.5991 | 35 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.4026 | 29 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 53.6423 | 57 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.0989 | 56 |